{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:50:47Z","timestamp":1787028647141,"version":"build-2736575974"},"reference-count":35,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: A glioma is a form of tumor that is abundant in blood vessels. Vascular endothelial growth factor receptor (VEGFR) and its receptor 2 (VEGFR2) are important in the process of angiogenesis. The relationship between VEGFR2 rs2071559 and glioma development is currently uncertain. The present study aims to analyze the correlation between VEGFR2 rs2071559 gene polymorphism and the susceptibility to gliomas. Methods: A thorough search was carried out in the Cochrane Library, Scopus, and Medline databases from inception until 20 February 2024 using a mix of pertinent keywords. We used random-effects models to examine the odds ratio (OR) and reported the results together with their respective 95% confidence intervals (CIs). Results: A total of six studies were incorporated. The results of our meta-analysis indicated that all genetic models of VEGFR2 rs2071559 gene polymorphism, starting from dominant (OR 1.40; p &lt; 0.00001), recessive (OR 1.52; p &lt; 0.0001), CC genotype (OR 1.78; p &lt; 0.00001), CT genotype (OR 1.30; p &lt; 0.0001), and C allele (OR 1.41; p &lt; 0.00001), were associated with a higher risk of developing gliomas. The subgroup analysis revealed a higher OR for studies with a sample size of \u2265500, originated from Asia, with a mean age of \u226542.3 years, and a male prevalence of &lt;57%. Conclusions: This study suggests that VEGFR2 rs2071559 gene polymorphism is associated with a higher risk of gliomas.<\/jats:p>","DOI":"10.3390\/jcm13154332","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:11:36Z","timestamp":1721887896000},"page":"4332","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) rs2071559 Gene Polymorphism and the Risk of Gliomas: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7514-6923","authenticated-orcid":false,"given":"Patricia Diana","family":"Prasetiyo","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Pelita Harapan University, Tangerang 15811, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eka Julianta","family":"Wahjoepramono","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Pelita Harapan University, Tangerang 15811, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1038\/nrdp.2015.17","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Seker-Polat, F., Pinarbasi Degirmenci, N., Solaroglu, I., and Bagci-Onder, T. (2022). Tumor Cell Infiltration into the Brain in Glioblastoma: From Mechanisms to Clinical Perspectives. Cancers, 14.","DOI":"10.3390\/cancers14020443"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.2147\/OTT.S174316","article-title":"The surgical perspective in precision treatment of diffuse gliomas","volume":"12","author":"Thon","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_5","unstructured":"Wang, Z.C. (2004). Wang Zhongcheng Neurosurgery, Wuhan Hubei Science and Technology Press. [2nd ed.]."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3322\/caac.21613","article-title":"Management of glioblastoma: State of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41582-019-0220-2","article-title":"Genetic and molecular epidemiology of adult diffuse glioma","volume":"15","author":"Molinaro","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yao, X., Ping, Y., Liu, Y., Chen, K., Yoshimura, T., Liu, M., Gong, W., Chen, C., Niu, Q., and Guo, D. (2013). Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS ONE, 8.","DOI":"10.1371\/annotation\/aed5b555-b826-4591-8aa6-284ad888627d"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"417413","DOI":"10.1155\/2013\/417413","article-title":"VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2","volume":"2013","author":"Xu","year":"2013","journal-title":"Sci. World J."},{"key":"ref_10","first-page":"812","article-title":"Correlation between the levels of vascular endothelial growth factor and its receptor Flt-1 and KDR in human brain glioma","volume":"18","author":"Liu","year":"2006","journal-title":"Zhong Liu Yan Jiu Yu Lin Chuang"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12031-012-9705-9","article-title":"Association between genetic variations of vascular endothelial growth factor receptor 2 and glioma in the Chinese Han population","volume":"47","author":"Chen","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s12035-015-9239-6","article-title":"Genetic Variations of Kinase Inserts Domain Receptor (KDR) Gene Are Associated with the Risk of Astrocytomas","volume":"53","author":"Gao","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"ref_16","first-page":"1007","article-title":"Possible association between polymorphisms of VEGFR2 rs2071559 and glioma risk in Chinese population","volume":"14","author":"Huang","year":"2014","journal-title":"Chin. J. Contemp. Neurol. Neurosurg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8808422","DOI":"10.1155\/2023\/8808422","article-title":"Association of Kinase-Insert-Domain-Containing Receptor Polymorphisms with Glioma Susceptibility in a Chinese Population: A Hospital-Based Case-Control Study","volume":"2023","author":"Huang","year":"2023","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Vasconcelos, V.C.A., Louren\u00e7o, G.J., Brito, A.B.C., Vasconcelos, V.L., Maldaun, M.V.C., Tedeschi, H., Marie, S.K.N., Shinjo, S.M.O., and Lima, C.S.P. (2019). Associations of VEGFA and KDR single-nucleotide polymorphisms and increased risk and aggressiveness of high-grade gliomas. Tumour Biol., 41.","DOI":"10.1177\/1010428319872092"},{"key":"ref_19","first-page":"16724","article-title":"Correlation between VEGFR2 rs2071559 polymorphism and glioma risk among Chinese population","volume":"8","author":"Xu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","article-title":"Publication bias in meta-analysis: Its causes and consequences","volume":"53","author":"Thornton","year":"2000","journal-title":"J. Clin. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/sim.1461","article-title":"Adjusting for publication bias in the presence of heterogeneity","volume":"22","author":"Terrin","year":"2003","journal-title":"Stat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/84635","article-title":"VEGF-D promotes the metastatic spread of tumor cells via the lymphatics","volume":"7","author":"Stacker","year":"2001","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","article-title":"Vascular endothelial growth factor (VEGF) and its receptors","volume":"13","author":"Neufeld","year":"1999","journal-title":"FASEB J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/clinpract12060108","article-title":"Implications of Cellular Immaturity in Necrosis and Microvascularization in Glioblastomas IDH-Wild-Type","volume":"12","author":"Orasanu","year":"2022","journal-title":"Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.critrevonc.2006.01.004","article-title":"Angiogenesis in malignant glioma\u2014A target for antitumor therapy?","volume":"59","author":"Tuettenberg","year":"2006","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_27","first-page":"7690","article-title":"Progress in the study of markers related to glioma prognosis","volume":"24","author":"Luo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/revneuro-2020-0062","article-title":"VEGF levels in patients with glioma: A systematic review and meta-analysis","volume":"32","author":"Seyedmirzaei","year":"2020","journal-title":"Rev. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2289","DOI":"10.1002\/mgg3.2289","article-title":"Association of KDR (rs2071559, rs1870377), CFH (rs1061170, rs1410996) genes variants and serum levels with pituitary adenoma","volume":"12","author":"Bruzaite","year":"2024","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1161\/STROKEAHA.109.554394","article-title":"VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence","volume":"40","author":"Zhang","year":"2009","journal-title":"Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10528-023-10419-4","article-title":"The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients","volume":"62","author":"Abdelgalil","year":"2023","journal-title":"Biochem. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1349-7006.2011.02194.x","article-title":"Potentially functional genetic variants in KDR gene as prognostic markers in patients with resected colorectal cancer","volume":"103","author":"Dong","year":"2012","journal-title":"Cancer Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12032-014-0209-z","article-title":"The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenib","volume":"31","author":"Zheng","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10456-019-09668-y","article-title":"Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients","volume":"22","author":"Sullivan","year":"2019","journal-title":"Angiogenesis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106551","DOI":"10.18632\/oncotarget.22533","article-title":"Single nucleotide polymorphisms as prognostic and predictive biomarkers in renal cell carcinoma","volume":"8","author":"Espinosa","year":"2017","journal-title":"Oncotarget"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4332\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:22:59Z","timestamp":1760109779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/15\/4332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,25]]},"references-count":35,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13154332"],"URL":"https:\/\/doi.org\/10.3390\/jcm13154332","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,25]]}}}